Wealth Enhancement Advisory Services, LLC Ironwood Pharmaceuticals Inc Call Options Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
181Shares Held
158MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$42.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$30.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$30 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$29.6 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$15.6 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $285M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...